Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses

纳他珠单抗和富马酸治疗对多发性硬化症患者的 CD4+ T 细胞和 B 细胞亚型具有不同的调节作用，且不影响持久的 COVID-19 疫苗应答。